These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 22732017

  • 1. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.
    Cope S, Zhang J, Williams J, Jansen JP.
    BMC Pulm Med; 2012 Jun 25; 12():29. PubMed ID: 22732017
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
    Cope S, Donohue JF, Jansen JP, Kraemer M, Capkun-Niggli G, Baldwin M, Buckley F, Ellis A, Jones P.
    Respir Res; 2013 Oct 07; 14(1):100. PubMed ID: 24093477
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
    Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP.
    Value Health; 2012 May 07; 15(3):524-33. PubMed ID: 22583463
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J, Karner C, Poole P.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD009157. PubMed ID: 22972134
    [Abstract] [Full Text] [Related]

  • 5. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA, Cates CJ.
    Cochrane Database Syst Rev; 2015 Oct 22; (10):CD008989. PubMed ID: 26490945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.
    Cope S, Kraemer M, Zhang J, Capkun-Niggli G, Jansen JP.
    Int J Chron Obstruct Pulmon Dis; 2012 Oct 22; 7():415-20. PubMed ID: 22848154
    [Abstract] [Full Text] [Related]

  • 9. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
    Karner C, Cates CJ.
    Cochrane Database Syst Rev; 2012 Apr 18; 4(4):CD008989. PubMed ID: 22513969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D.
    Respir Med; 2013 Feb 18; 107(2):223-32. PubMed ID: 23219347
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis.
    Huisman EL, Cockle SM, Ismaila AS, Karabis A, Punekar YS.
    Int J Chron Obstruct Pulmon Dis; 2015 Feb 18; 10():1863-81. PubMed ID: 26392761
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
    Kerstjens HA, Deslée G, Dahl R, Donohue JF, Young D, Lawrence D, Kornmann O.
    Pulm Pharmacol Ther; 2015 Jun 18; 32():101-8. PubMed ID: 25743376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.